The T-cell—the all-powerful immune system player—is at the core of groundbreaking research at the UCLA Jonsson Comprehensive Cancer Center. Researchers collaborate across disciplines such as oncology, immunology and virology to genetically engineer T-cells and translate their discoveries into treatment strategies for a wide range of cancer types. Working with the PICI network, UCLA investigators are furthering research to learn more about the immune system’s role in the fight against cancer. Antoni Ribas, MD, PhD | Director Owen Witte, MD | Co-Director All Investigators Related Announcement, Our Impact, Research Update New CAR-T Approach Shows Promise for Lymphoma Patients Announcement PICI Young Investigator Retreat 2019 Research Update Colorectal cancer genetics study sheds light on why some patients are resistant to treatment Announcement, Press Release PICI Network Shapes Future of Immunotherapy at AACR 202 Announcement, Press Release PICI and CVC Unite to Accelerate Cancer Vaccines Announcement, Press Release Parker Institute for Cancer Immunotherapy Appoints Bolyn Hubby as Chief of Staff to Strengthen Organization Excellence During Period of Growth Announcement, Press Release Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer Announcement, Press Release Parker Institute for Cancer Immunotherapy Collaborates with Conquer Cancer and ASCO to Support Promising Cancer Research Announcement Parker Institute for Cancer Immunotherapy Announces Appointment of Mark Veich as Chief Organizational Advancement Officer
Research Update Colorectal cancer genetics study sheds light on why some patients are resistant to treatment
Announcement, Press Release Parker Institute for Cancer Immunotherapy Appoints Bolyn Hubby as Chief of Staff to Strengthen Organization Excellence During Period of Growth
Announcement, Press Release Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer
Announcement, Press Release Parker Institute for Cancer Immunotherapy Collaborates with Conquer Cancer and ASCO to Support Promising Cancer Research
Announcement Parker Institute for Cancer Immunotherapy Announces Appointment of Mark Veich as Chief Organizational Advancement Officer